Legend Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 28

- Investments
- 701
- Portfolio
- 353
- Exits
- 154

Legend Capital General Information
Description
Founded in 2001, Legend Capital is an investment firm based in Beijing, China. The firm focuses on early-stage venture capital and growth-stage investment. The firm invests in Chinese companies operating in the telecommunications, media, technology, healthcare, consumption, culture and sports, enterprise services, and intelligent manufacturing sectors.
Contact Information
- 16F, Tower B, Raycom Infotech Park
- Number 2 Kexueyuan South Road, Zhongguancun, Haidian District
- Beijing, 100190
- China
Legend Capital Investments & Acquisitions (701)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Spectrumedics | 07-May-2022 | Early Stage VC | 000.00 | Therapeutic Devices | Generating Revenue | |
000000 000 | 25-Apr-2022 | 00000 00000 | 000.00 | Laboratory Services (Healthcare) | Startup | |
00000.00 | 18-Apr-2022 | 00000 00000 | Automation/Workflow Software | Generating Revenue | ||
000000 00000000000 | 13-Apr-2022 | 00000 00000 | Drug Discovery | Generating Revenue/Not Profitable | 000 00 | |
000000000 00000000 | 29-Mar-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
000000000 | 21-Mar-2022 | 00000 00000 | 000.00 | Educational and Training Services (B2C) | Generating Revenue | |
00000000 000000000 | 14-Mar-2022 | 00000 00000 | 00000 | Drug Discovery | Pre-Clinical Trials | |
00000000 00000000 | 14-Mar-2022 | 00000 00000 | Other Materials | Generating Revenue | ||
GS Biotech | 28-Feb-2022 | Early Stage VC | Specialty Chemicals | Startup | ||
GluBio Pharmaceutical | 28-Feb-2022 | Early Stage VC | 0000 | Drug Discovery | Startup |
Legend Capital Exits (154)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Fortior (Industrial Supplies and Parts) | 20-Apr-2022 | IPO | 00000 |
00000000 | 11-Apr-2022 | 000 00 00000000 | |
000000 | 30-Mar-2022 | 000 | 000.00 |
0000 | 18-Mar-2022 | 000 | 00000 |
0000000 | 14-Jan-2022 | 0000000 000000 | 00000 |
00000000 | 07-Jan-2022 | 000000000 00000000 | 000.00 |
00000000 000000000 | 23-Dec-2021 | 000 | 000.00 |
00 00000-0000 0000 | 13-Dec-2021 | 000 | 00000 |
AoHua | 15-Nov-2021 | IPO | 00000 |
Mathpresso | 09-Nov-2021 | Later Stage VC |
Legend Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Legend Capital‘s full profile, request access.
Request a free trialLegend Capital Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialLegend Capital Team (43)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Chen Hao | Managing Director & President | 0 | 0 | Beijing, China | |
Jiaqing Li | President & Managing Director | 00 | 0 | 0 | Beijing, China |
Nengguang Wang | Co-Founder, Managing Director & Chief Financial Officer | 0 | Beijing, China | ||
Hank Zhou Ph.D | Managing Director & Chief Investment Officer | 0 | 0 | Beijing, China | |
Junfeng Wang | Managing Director & Chief Investment Officer | 0 | 0 | 0 | Beijing, China |
Legend Capital Co-Investors (495)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Hillhouse Capital Group | 17 | 0 |
![]() |
![]() |
|
Qiming Venture Partners | 00 | 0 | 0 |
![]() |
![]() |
IDG Capital | 00 | 0 | 0 |
![]() |
![]() |
Sequoia Capital China | 00 | 0 |
![]() |
![]() |
|
Eastern Bell Venture Capital | 0 | 0 |
![]() |
![]() |